|
09 Oct 2019 |
Annexon Biosciences Reports Top-line Phase 1b Results for Novel C1q Inhibitor ANX007 in Glaucoma
|
|
09 Oct 2019 |
City of Hope Is Enrolling Patients in First of Its Kind Clinical Trial for Brain Tumor Patients
|
|
09 Oct 2019 |
Novartis data show more patients are completely symptom-free from chronic spontaneous urticaria with ligelizumab (QGE031) than Xolair® 300 mg
|
|
08 Oct 2019 |
FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder
|
|
08 Oct 2019 |
Azitra Presents Data Showing Tolerability of its Lead Product Candidate ATR-04
|
|
08 Oct 2019 |
AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
|
|
08 Oct 2019 |
FDA Approves Octapharma’s WILATE® for Hemophilia A in Adult and Adolescent Patients
|
|
08 Oct 2019 |
Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis
|
|
08 Oct 2019 |
GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
|
|
08 Oct 2019 |
Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells
|
|
08 Oct 2019 |
Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
|
|
08 Oct 2019 |
Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
|
|
08 Oct 2019 |
ONL Therapeutics Announces First-In-Human Clinical Study with ONL1204
|
|
08 Oct 2019 |
ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy
|
|
08 Oct 2019 |
Intarcia Therapeutics Provides Regulatory Update - FDA Accepts Resubmitted New Drug Application For ITCA 650
|
|
08 Oct 2019 |
4D Pharma Collaborates With MSD to Develop Live Biotherapeutics for Vaccines
|
|
08 Oct 2019 |
IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors outside of Uveal Melanoma and a Collaboration with Foundation Medicine in support of its Tumor-Agnostic GNAQ/11 Basket Trial
|
|
08 Oct 2019 |
Stealth BioTherapeutics Presents Data on SBT-272 in Neurodegeneration
|
|
08 Oct 2019 |
Nektar Therapeutics Announces Initiation of Two Clinical Studies of Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Psoriasis and Atopic Dermatitis
|
|
08 Oct 2019 |
Prokarium Secures £4.6M from Wellcome to Fund the Clinical Development of its Lead Vaccine Programme
|
